Privia Health Group, Inc. (PRVA) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 603.85M | 541.17M | 580.42M | 521.15M | 480.1M | 460.9M | 437.92M | 422.33M | 415.24M | 440.83M | 417.28M | 413.35M |
| Revenue Growth % | 25.78% | 17.42% | 32.54% | 23.4% | 15.62% | 4.55% | 4.95% | 2.17% | 7.5% | 20.97% | 21.69% | 23.19% |
| Cost of Goods Sold | 546.82M | 491.52M | 519.41M | 473.49M | 434.33M | 412.93M | 392.57M | 379.64M | 374.39M | 401.79M | 375.55M | 371.92M |
| COGS % of Revenue | 90.56% | 90.82% | 89.49% | 90.85% | 90.47% | 89.59% | 89.64% | 89.89% | 90.16% | 91.14% | 90% | 89.98% |
| Gross Profit | 57.03M | 49.66M | 61M | 47.66M | 45.76M | 47.97M | 45.35M | 42.68M | 40.85M | 39.04M | 41.74M | 41.43M |
| Gross Margin % | 9.44% | 9.18% | 10.51% | 9.15% | 9.53% | 10.41% | 10.36% | 10.11% | 9.84% | 8.86% | 10% | 10.02% |
| Gross Profit Growth % | 24.62% | 3.52% | 34.51% | 11.66% | 12.02% | 22.86% | 8.66% | 3.02% | 3.97% | 6.34% | 23.17% | 22.43% |
| Operating Expenses | 49.61M | 38.38M | 46.6M | 44.32M | 40.54M | 42.72M | 39.54M | 37.59M | 40.03M | 37.62M | 36.2M | 34.45M |
| OpEx % of Revenue | 8.22% | 7.09% | 8.03% | 8.51% | 8.45% | 9.27% | 9.03% | 8.9% | 9.64% | 8.53% | 8.68% | 8.34% |
| Selling, General & Admin | 49.61B | 35.72M | 46.6M | 44.32M | 38.64M | 40.89M | 37.74M | 35.77M | 38.21M | 35.85M | 34.47M | 32.76M |
| SG&A % of Revenue | 8215.16% | 6.6% | 8.03% | 8.51% | 8.05% | 8.87% | 8.62% | 8.47% | 9.2% | 8.13% | 8.26% | 7.93% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -1000K | 1000K | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Operating Income | 7.42M | 11.28M | 14.4M | 3.34M | 5.22M | 5.25M | 5.81M | 5.1M | 823K | 1.42M | 5.54M | 6.98M |
| Operating Margin % | 1.23% | 2.08% | 2.48% | 0.64% | 1.09% | 1.14% | 1.33% | 1.21% | 0.2% | 0.32% | 1.33% | 1.69% |
| Operating Income Growth % | 42.24% | 114.9% | 147.77% | -34.56% | 534.02% | 269.58% | 5% | -26.95% | -87.74% | -36.86% | 221.03% | 232.93% |
| EBITDA | 10.7M | 13.94M | 17.17M | 5.92M | 7.12M | 7.08M | 7.61M | 6.92M | 2.64M | 3.19M | 7.27M | 8.67M |
| EBITDA Margin % | 1.77% | 2.57% | 2.96% | 1.14% | 1.48% | 1.54% | 1.74% | 1.64% | 0.64% | 0.72% | 1.74% | 2.1% |
| EBITDA Growth % | 50.34% | 96.82% | 125.61% | -14.42% | 169.25% | 121.8% | 4.72% | -20.22% | -67.17% | -5.67% | 312.42% | 312.22% |
| D&A (Non-Cash Add-back) | 3.28M | 2.66M | 2.77M | 2.58M | 1.9M | 1.83M | 1.8M | 1.82M | 1.82M | 1.77M | 1.73M | 1.69M |
| EBIT | 7.42M | 11.28M | 16.67M | 5.74M | 5.22M | 5.25M | 5.81M | 5.1M | 823K | 1.42M | 5.54M | 6.98M |
| Net Interest Income | 1.89M | 2.09M | 2.27M | 2.41M | 2.93M | 2.77M | 2.16M | 2.97M | 2.98M | 2.85M | 2.89M | 817K |
| Interest Income | 1.89M | 2.09M | 2.27M | 2.41M | 2.93M | 2.77M | 2.16M | 2.97M | 2.98M | 2.85M | 2.89M | 817K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 1.89M | 2.09M | 2.27M | 2.41M | 2.93M | 2.77M | 2.16M | 2.97M | 2.98M | 2.85M | 2.89M | 817K |
| Pretax Income | 9.31M | 13.37M | 16.67M | 5.74M | 8.15M | 8.02M | 7.98M | 8.06M | 3.81M | 4.27M | 8.43M | 7.8M |
| Pretax Margin % | 1.54% | 2.47% | 2.87% | 1.1% | 1.7% | 1.74% | 1.82% | 1.91% | 0.92% | 0.97% | 2.02% | 1.89% |
| Income Tax | 5.6M | 2.79M | 6.87M | 2.46M | 2.1M | 2.65M | 4M | 3.42M | 751K | 1.94M | 2.49M | 1.44M |
| Effective Tax Rate % | 60.15% | 20.84% | 41.18% | 42.76% | 25.81% | 33.1% | 50.13% | 42.42% | 19.73% | 45.55% | 29.51% | 18.42% |
| Net Income | 3.06M | 9.15M | 6.86M | 2.69M | 4.22M | 4.4M | 3.54M | 3.47M | 2.98M | 2.84M | 5.64M | 7.27M |
| Net Margin % | 0.51% | 1.69% | 1.18% | 0.52% | 0.88% | 0.95% | 0.81% | 0.82% | 0.72% | 0.64% | 1.35% | 1.76% |
| Net Income Growth % | -27.39% | 108.02% | 94.09% | -22.5% | 41.42% | 55% | -37.36% | -52.34% | -59.26% | -84.03% | 247.48% | 169.44% |
| Net Income (Continuing) | 3.71M | 10.59M | 9.81M | 3.29M | 6.05M | 5.37M | 3.98M | 4.64M | 3.06M | 2.32M | 5.94M | 6.36M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 52.84B | 53.73M | 53.64M | 50.69M | 50.09M | 48.26M | 47.3M | 48.2M | 46.02M | 45.95M | 46.38M | 46.08M |
| EPS (Diluted) | 0.02 | 0.07 | 0.05 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.05 | 0.06 |
| EPS Growth % | -22% | 101.72% | 77.67% | -30.33% | 50% | 74% | -40% | -50% | -66.67% | -85.71% | - | 162.24% |
| EPS (Basic) | 0.02 | 0.07 | 0.06 | 0.02 | 0.03 | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 | 0.05 | 0.06 |
| Diluted Shares Outstanding | 130.88M | 130.37M | 128.78M | 128.45M | 127.75M | 126.42M | 125.75M | 125.32M | 125.05M | 124.83M | 124.92M | 124.57M |
| Basic Shares Outstanding | 124.15M | 123.19M | 122.77M | 122.13M | 120.62M | 120.14M | 119.66M | 119.3M | 118.51M | 118.11M | 117.6M | 116.16M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |